These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36143873)

  • 1. Efficiency of sFlt-1/PlGF Ratio in Preeclampsia Diagnosis.
    Tataru-Copos AF; Popescu MI; Murvai R; El Kharoubi A
    Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143873
    [No Abstract]   [Full Text] [Related]  

  • 2. Should angiogenic markers be included in diagnostic criteria of superimposed pre-eclampsia in women with chronic hypertension?
    Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
    Ultrasound Obstet Gynecol; 2022 Feb; 59(2):192-201. PubMed ID: 34165863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of biomarkers (sFlt-1/PlGF) in cases of COVID-19 for distinguishing preeclampsia and guiding clinical management.
    Nobrega GM; Guida JP; Novaes JM; Solda LM; Pietro L; Luz AG; Lajos GJ; Ribeiro-do-Valle CC; Souza RT; Cecatti JG; Mysorekar IU; Dias TZ; Laura Costa M
    Pregnancy Hypertens; 2023 Mar; 31():32-37. PubMed ID: 36525933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal Serum Angiogenic Factor sFlt-1 to PlGF Ratio in Preeclampsia: A Useful Marker for Differential Diagnosis and Prognosis Evaluation in Chinese Women.
    Lou WZ; Jiang F; Hu J; Chen XX; Song YN; Zhou XY; Liu JT; Bian XM; Gao JS
    Dis Markers; 2019; 2019():6270187. PubMed ID: 31396294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
    Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia.
    Saleh L; van den Meiracker AH; Geensen R; Kaya A; Roeters van Lennep JE; Duvekot JJ; Verdonk K; Steegers EAP; Russcher H; Danser AHJ; Visser W
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):751-757. PubMed ID: 28600845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Validation of the sFlt-1:PlGF Ratio as a Biomarker for Preeclampsia Diagnosis in a High-Risk Obstetrics Unit.
    Miller JJ; Higgins V; Melamed N; Hladunewich M; Ma L; Yip PM; Fu L
    J Appl Lab Med; 2023 May; 8(3):457-468. PubMed ID: 36869760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of preeclampsia in women with multiple pregnancy after assisted reproduction.
    Romanenko TG; Sulimenko OM
    Wiad Lek; 2020; 73(3):494-497. PubMed ID: 32285820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Values of serum sFlt-1, PLGF levels, and sFlt-1/PLGF ratio in diagnosis and prognosis evaluation of preeclamptic patients.
    Zhu X; Chen L; Li R
    Clin Exp Hypertens; 2020 Oct; 42(7):601-607. PubMed ID: 32338084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. sFlt-1/PlGF Ratio at 24 Weeks Gestation in Twin Pregnancies as a Predictor of Preeclampsia or Fetal Growth Restriction.
    Martínez-Varea A; Martínez-Sáez C; Domenech J; Desco-Blay J; Monfort-Pitarch S; Hueso M; Diago-Almela V
    Fetal Diagn Ther; 2022; 49(4):206-214. PubMed ID: 35609518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of serum and urinary soluble sFlt-1 and PLGF in the diagnosis of preeclampsia.
    Tang P; Xu J; Xie BJ; Wang QM
    Hypertens Pregnancy; 2017 Feb; 36(1):48-52. PubMed ID: 27834501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of preeclampsia with angiogenic biomarkers. Results from the prospective Odense Child Cohort.
    Andersen LB; Dechend R; Jørgensen JS; Luef BM; Nielsen J; Barington T; Christesen HT
    Hypertens Pregnancy; 2016 Aug; 35(3):405-19. PubMed ID: 27159383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
    Aggarwal PK; Chandel N; Jain V; Jha V
    J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. sFlT-1/PlGF ratio as a predictor of preeclampsia in COVID-19 pregnant patients.
    Pluta K; Januszewski M; Ziuzia-Januszewska L; Kudan M; Suchocka M; Kuśmierczuk K; Issat T; Jakimiuk AJ
    BMC Pregnancy Childbirth; 2024 Jan; 24(1):94. PubMed ID: 38297191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenic biomarkers for the follow-up of singleton pregnancies with suspected preeclampsia.
    Gómez Fernández C; Otero Naveiro A; Raña Mayán A; Álvarez Fernández R; Pérez Fernández R; Paz Fernández E
    Minerva Obstet Gynecol; 2023 Oct; 75(5):412-423. PubMed ID: 35758095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of repeated measurements of the sFlt-1/PlGF ratio for the prediction of preeclampsia and intrauterine growth restriction.
    Schoofs K; Grittner U; Engels T; Pape J; Denk B; Henrich W; Verlohren S
    J Perinat Med; 2014 Jan; 42(1):61-8. PubMed ID: 23929878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Threshold of soluble fms-like tyrosine kinase 1/placental growth factor ratio for the imminent onset of preeclampsia.
    Ohkuchi A; Hirashima C; Matsubara S; Takahashi K; Matsuda Y; Suzuki M
    Hypertension; 2011 Nov; 58(5):859-66. PubMed ID: 21947468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The predictive value of the sFlt-1/PlGF ratio on short-term absence of preeclampsia and maternal and fetal or neonatal complications in twin pregnancies.
    Saleh L; Tahitu SIM; Danser AHJ; van den Meiracker AH; Visser W
    Pregnancy Hypertens; 2018 Oct; 14():222-227. PubMed ID: 29678353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The New Possibilities in Early Diagnosis of Preeclampsia by Soluble fms-Like Tyrosine Kinase-1 and Placental Growth Factor in 16-20 Weeks Gestation.
    Benovská M; Opluštilová A; Pinkavová J; Hodická Z; Cermáková Z
    Lab Med; 2018 Mar; 49(2):112-117. PubMed ID: 29267975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of sFlt-1/PlGF ratio and feto-maternal Doppler for the prediction of adverse perinatal outcome in late-onset pre-eclampsia.
    Graupner O; Karge A; Flechsenhar S; Seiler A; Haller B; Ortiz JU; Lobmaier SM; Axt-Fliedner R; Enzensberger C; Abel K; Kuschel B
    Arch Gynecol Obstet; 2020 Feb; 301(2):375-385. PubMed ID: 31734756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.